Skip to content

Impact of Positive End-expiratory Pressure on Hepatic Venous Flow

Impact of Moderate Positive End-expiratory Pressure on Hepatic Venous Flow in Patients Undergoing Cardiac Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02700581
Enrollment
15
Registered
2016-03-07
Start date
2016-03-31
Completion date
2016-05-31
Last updated
2016-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valvular Heart Disease

Brief summary

The purpose of this study is to determine the difference in the impact of moderate positive end-expiratory pressure (PEEP) on hepatic venous flow Doppler in patients undergoing cardiac surgery: conventional versus protective ventilation strategy The possible changes in forward and backward flows (Doppler profiles) of hepatic venous flow at different degrees of PEEP in conventional and protective ventilation strategies are analyzed by using intraoperative transesophageal echocardiography (TEE) in patients undergoing cardiac surgery .

Detailed description

Following data would be determined after 5 min-exposure volume controlled ventilation employing tidal volume of 10 ml/kg and 6 ml/kg with low PEEP (with 2 mmHg) and moderate PEEP (7 mmHg) during remifentanil-based anesthesia (1.0 mcg/kg/min) for cardiac surgery (n=12) 1. sum of forward hepatic venous flow 2. sum of backward hepatic venous flow 3. peak velocity of diastolic hepatic venous flow 4. lung compliance 5. peak airway pressure 6. mean airway pressure 7. other pressure derived hemodynamic parameters:heart rate; systolic, diastolic, and mean blood pressures; systolic, diastolic, and mean pulmonary artery pressures; central venous pressure (CVP), pulmonary capillary

Interventions

PROCEDURElow PEEP conventional ventilation
PROCEDUREmoderate PEEP conventional ventilation
PROCEDURElow PEEP protective ventilation
PROCEDUREmoderate PEEP protective ventilation

Sponsors

Konkuk University Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients undergoing cardiac surgery * Patients provide written informed consents

Exclusion criteria

* Re-do or tri-do surgery * Patients with active infection * Patients with endocrine disease * Patients ischemic heart disease * patients with tricuspid valve regurgitation greater than mild degree

Design outcomes

Primary

MeasureTime frameDescription
forward hepatic venous flow3 min after interventionHepatic venous flow Doppler, cm/sec, by transesophageal echocardiography

Secondary

MeasureTime frameDescription
reversed hepatic venous flow3 min after interventionReversed hepatic venous flow Doppler, cm/sec, by transesophageal echocardiography

Contacts

Primary ContactTae-Yop Kim, MD, PhD
taeyop@gmail.com+82222926942

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026